A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus | MicrobiomeTrials← Back to trialsNCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-01-21Est. Completion: 2026-12
Enrollment target: 24 participants Locations- AARA Clinical Research, Avondale, Arizona, United States
- AARA Clinical Research, Tucson, Arizona, United States
- Omega Research Group, Orlando, Florida, United States
- University of Iowa, Iowa City, Iowa, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- NYU Grossman School of Medicine, New York, New York, United States
- Columbia University Medical Center, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
- Regional One Health, Memphis, Tennessee, United States
- Stryde Research, Plano, Texas, United States
- Tranquil Clinical Research, Webster, Texas, United States
- Intermountain Health, Salt Lake City, Utah, United States
- Royal Melbourne Hospital, Parkville, Australia
- Osteoporosis Solutions, Victoria Park, Australia
- Multi profile Hospital for Active Treatment Sveta Sofia, Sofia, Bulgaria
- CHU de Nantes, Nantes, France
- University Hospital Saint Etienne, Saint-Priest-en-Jarez, France
Other microbiome trials you might be interested in
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
Background:
Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. Peop…
Bethesda, United StatesEst. completion May 31, 2027
Centre Hospitalier Universitaire de Toulouse, Toulouse, FranceARENSIA Exploratory Medicine, LLC, Tbilisi, GeorgiaKlinikum der Ruprecht-Karls Universitaet Heidelberg, Heidelberg, Baden-Wurttemberg, GermanyTimofei Moșneaga Republican Clinical Hospital, Chisinau, MoldovaARENSIA Exploratory Medicine S.R.L., Bucharest, RomaniaArensia Exploratory Medicine, Cluj-Napoca, RomaniaHospital Quironsalud Infanta Luisa, Seville, SpainSystemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is an autoimmune rheumatic disease. Patients report that fatigue has a significant im…
Edinburgh, United KingdomEst. completion Mar 9, 2026